Clinical Trial Update: Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the neuro-protective effect of granulocyte colony-stimulating factor in early Parkinson disease was terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Parkinson Disease | Phase 2 | Status: TERMINATED | Results posted: 2016-04-04